Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedFeb 24, 2026
DataAggregated Company Financials
Companies5
  • 7D-1.8%
  • 3M-11.3%
  • 1Y-4.6%
  • YTD-9.6%

Over the last 7 days, the Biotech industry has dropped 1.8%, driven by Genmab declining 2.1%. The industry has fallen 4.6% in the last year. Looking forward, earnings are forecast to decline by 2.7% per year.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 24 Feb 2026DKK 155.2bDKK 39.7bDKK 14.9b6.2x10.4x3.9x
Thu, 22 Jan 2026DKK 173.4bDKK 40.6bDKK 19.0b6.3x9.1x4.3x
Sat, 20 Dec 2025DKK 175.5bDKK 40.6bDKK 19.0b6.1x9.2x4.3x
Mon, 17 Nov 2025DKK 170.8bDKK 40.8bDKK 19.1b5.6x9x4.2x
Wed, 15 Oct 2025DKK 180.7bDKK 39.1bDKK 16.8b12.6x10.7x4.6x
Fri, 12 Sep 2025DKK 161.4bDKK 38.8bDKK 16.7b12.9x9.6x4.2x
Sun, 10 Aug 2025DKK 127.5bDKK 29.7bDKK 8.8b11.8x14.4x4.3x
Tue, 08 Jul 2025DKK 120.1bDKK 26.9bDKK 7.3b10.5x16.4x4.5x
Thu, 05 Jun 2025DKK 136.2bDKK 27.4bDKK 7.5b11.3x18.2x5x
Sat, 03 May 2025DKK 136.1bDKK 27.3bDKK 7.7b11.9x17.7x5x
Mon, 31 Mar 2025DKK 138.7bDKK 27.3bDKK 7.7b11.8x18.1x5.1x
Wed, 26 Feb 2025DKK 169.0bDKK 27.7bDKK 7.8b12.7x21.6x6.1x
Fri, 24 Jan 2025DKK 164.8bDKK 26.0bDKK 4.7b17.1x35.1x6.3x
Sun, 22 Dec 2024DKK 160.1bDKK 26.0bDKK 4.7b16.6x34.1x6.2x
Tue, 19 Nov 2024DKK 156.0bDKK 26.0bDKK 4.7b16.4x33.2x6x
Thu, 17 Oct 2024DKK 172.2bDKK 25.5bDKK 5.5b20.7x31.5x6.8x
Sat, 14 Sep 2024DKK 199.3bDKK 25.5bDKK 5.5b23.8x36.4x7.8x
Mon, 12 Aug 2024DKK 193.4bDKK 26.0bDKK 5.7b17.9x33.9x7.4x
Wed, 10 Jul 2024DKK 194.6bDKK 24.8bDKK 5.6b17.6x34.6x7.8x
Fri, 07 Jun 2024DKK 180.1bDKK 24.8bDKK 5.6b18.6x32x7.3x
Sun, 05 May 2024DKK 184.7bDKK 25.2bDKK 6.2b16.3x30x7.3x
Tue, 02 Apr 2024DKK 190.9bDKK 23.9bDKK 5.0b19.7x38x8x
Thu, 29 Feb 2024DKK 176.9bDKK 22.8bDKK 4.3b22.9x41.4x7.8x
Sat, 27 Jan 2024DKK 167.0bDKK 23.3bDKK 4.2b22.9x40.1x7.2x
Mon, 25 Dec 2023DKK 175.3bDKK 23.3bDKK 4.2b25.7x42.1x7.5x
Wed, 22 Nov 2023DKK 171.2bDKK 23.3bDKK 4.2b24.4x41.1x7.3x
Fri, 20 Oct 2023DKK 158.5bDKK 22.0bDKK 4.7b18.3x33.5x7.2x
Sun, 17 Sep 2023DKK 203.4bDKK 22.0bDKK 4.7b23.5x43x9.2x
Tue, 15 Aug 2023DKK 192.1bDKK 20.6bDKK 3.9b37.8x49.7x9.3x
Thu, 13 Jul 2023DKK 196.9bDKK 19.5bDKK 4.4b40.4x44.7x10.1x
Sat, 10 Jun 2023DKK 206.9bDKK 19.5bDKK 4.4b43.5x47x10.6x
Mon, 08 May 2023DKK 205.8bDKK 17.9bDKK 4.1b32.3x50.3x11.5x
Wed, 05 Apr 2023DKK 195.5bDKK 17.9bDKK 3.5b30.2x55.3x10.9x
Fri, 03 Mar 2023DKK 196.8bDKK 17.3bDKK 3.1b30.3x62.7x11.3x
Price to Earnings Ratio

62.7x


Total Market Cap: DKK 196.8bTotal Earnings: DKK 3.1bTotal Revenue: DKK 17.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 31.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.4x which is lower than its 3-year average PE of 31.1x.
  • The 3-year average PS ratio of 7.0x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 68% per year over the last three years.
  • Revenues for these companies have grown 32% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-6.24%
Healthcare-14.14%
Biotech-1.79%
Biotech-1.79%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAVA Bavarian NordicDKK 194.552.6%
+DKK 375.9m		12.7%PE6.2x
STRAP Strategic PartnersDKK 590.005.0%
+DKK 1.2m		-28.4%PB1.4x

Latest News

GMAB
DKK 1,832.50
Genmab
7D
-2.1%
1Y
14.7%
ZEAL
DKK 378.30
Zealand Pharma
7D
-3.0%
1Y
-46.6%
BAVA
DKK 194.55
Bavarian Nordic
7D
2.6%
1Y
12.7%

BAVA: Share Buybacks And Latin America Vaccine Deal Will Support Upside

Analysts now keep their DKK 250 price target for Bavarian Nordic intact, as slightly higher discount and future P/E assumptions together with a modestly stronger profit margin view offset softer revenue growth expectations. What's in the News Bavarian Nordic issued earnings guidance for fiscal 2026, indicating expected revenue in the range of DKK 5,000 million to DKK 5,200 million (Corporate guidance).
BIOPOR
DKK 0.96
BioPorto
7D
-1.1%
1Y
-36.4%
STRAP
DKK 590.00
Strategic Partners
7D
5.0%
1Y
-28.4%